(Q79995276)
Statements
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230) (English)
Glen Clack
Rosemary A Hannon
Jack Cuzick
Mitch Dowsett
Judith E Adams
ATAC Trialists' group